Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- India in the Semicon Party - All that and a bag of chips! Not yet
- Local push in rare earth magnet sops
- 75% of industry leaders strongly believe responsible AI can significantly improve decision-making and governance – Primus Partners Report
- The West's Monopoly On ESG Ratings And Why India Needs A Swadeshi Lens
